The COVID-19 pandemic impacted the Indian spine surgery market to a great extent. For instance, according to an article published in December 2021, due to the reallocation of resources to the care of COVID-19 patients, the COVID-19 pandemic resulted in the suspension of elective procedures. In addition, over one-third of elective spine surgeries were canceled during the pandemic. Such instances were anticipated to have an adverse impact on the demand for Indian spinal surgery devices during the pandemic phase.
However, the market is expected to witness a high growth rate in the coming future owing to the increasing demand for spinal surgery devices and the resumption of elective surgeries. For instance, as per Stryker’s annual report 2021, the company reported a growth in the overall revenue from the spine segment. The spine segment generated a revenue of USD 1,167 million in FY2021 compared to USD 1,047 million in FY2020. Thus, the market is expected to gain traction during the coming years.
Factors such as the rising prevalence of obesity in India, the increasing adoption rate of minimally invasive spinal surgeries, and growing technological advancements in spinal surgery are boosting market growth.
The increasing burden of obesity and diabetes among the population is the key factor driving the market growth. For instance, according to the 2022 statistics published by UNICEF World Obesity Atlas, more than 27 million children are expected to suffer from obesity by 2030 in India. Thus, the increasing number of people with obesity frequently develop symptoms associated with spinal disorders such as spinal stenosis that further boost the demand for spinal implant surgeries, thereby propelling the market growth.
Also, as per 2022 statistics published by IDF, 74.1 million people were living with diabetes in India in 2021, and this number is projected to increase to 92.9 million by 2030 and 124.8 million by 2045. The high glucose level in the body converts into fatty acids and gets stored as fats in adipose tissues, resulting in obesity. This is anticipated to increase the risk of developing spinal diseases, increasing the demand for spinal injuries and propelling the growth of the market studied.
Additionally, a study published in the Journal of Global Health in November 2021 observed that the prevalence of back/neck pain among adults was higher compared to non-specific neck pain. Also, as per the same source, the prevalence of non-specific back/neck pain and radiculopathy was higher among females than males. The higher incidence of lower back pain among the Indian population is anticipated to increase the demand for spine-related issues. This is expected to boost the demand for spinal surgeries, boosting the market growth.
Furthermore, minimally invasive spine surgery (MISS) offers an alternative to conventional open surgical techniques for treating a variety of spinal problems, including spinal stenosis, degenerative disc disease, herniated discs, and scoliosis. These minimally invasive spine surgeries offer numerous possible benefits, such as smaller incisions, less cutting into soft tissues (such as ligaments and muscles), outpatient possibilities, reduced post-operative pain, and quicker recovery.
Moreover, companies focusing on developing spine surgery products and adopting business strategies, such as partnerships and acquisitions, are also contributing to the market growth. For instance, in September 2021, Medtronic expanded its minimally invasive spine surgery ecosystem with next-generation spinal technologies such as Catalyft PL and PL40 (helps in simplifying bone graft delivery and active expansion at the precise angle), Space-D Access System, and Accelerate Graft Delivery System with Grafton DBF. Also, in February 2022, Zimmer Biomet spun off its spine and dental device businesses to form a new and independent publicly traded company. This will enhance the focus of both Zimmer Biomet and the new company to meet the needs of patients. Such developments are fueling the adoption and demand for spinal surgery devices, thereby contributing to the market's growth.
Therefore, due to the aforementioned factors, the market studied is expected to grow during the forecast period. However, the expensive treatment procedures and the stringent regulatory process for new product approvals are likely to hinder the growth of spinal surgery devices in India during the forecast period.
India Spinal Surgery Devices Market Trends
Thoracolumbar Fusion Segment is Expected to Register High CAGR Over the Forecast Period in the India Spinal Surgery Devices MarketThe thoracolumbar fusion segment is expected to witness significant growth over the forecast period, owing to the factors such as the increasing numbers of spinal disorders and the growing geriatric population. As per the data published by the National Health Portal of India in November 2021, about 15,000 cases of spinal cord injuries are recorded in India every year. The high number of spinal injury cases is expected to increase the demand for spinal surgeries due to unstable spines, thereby propelling the growth of the segment. Trauma, falls, crashes, and traffic accidents are all common causes of spinal fusion injuries.
Thoracolumbar fusion is a complex operation and requires the use of screws that are placed between the vertebrae to be fused. Then the bone graft is placed around these screws. The screws that are used during this operation are made of titanium and are usually placed for a lifetime. It provides an effective treatment option for patients suffering from lumbar spinal stenosis and advanced alternative treatment for decompression spinal surgery. The physiological changes in the body of older people and prolonged exposure to risk factors increase the incidence rates of spine disorders, which may require surgical intervention.
Moreover, the focus of several companies on developing new and effective devices that are used to treat spine-related issues also contributes to the growth of thoracolumbar fusion devices, thereby increasing the market growth. For instance, in June 2022, Camber Spine announced that it is entering into the next phase of the complete national launch of the SPIRA-P Posterior Lumbar Spacer and has commercialized its Spira-T Oblique Posterior Lumbar Spacer. Also, in April 2021, Globus Medical Inc. launched CREO ONE, the first robotic screw designed for spine surgery with ExcelsiusGPS. This launch enhances the company’s groundbreaking modular pedicle screw platform by simplifying pedicle preparation while maintaining navigational accuracy.
Therefore, owing to the aforementioned factors, the segment studied is expected to grow during the forecast period.
Interbody Fusion Segment is Expected to Have a Significant Market Share Over the Forecast PeriodThe interbody fusion segment is expected to grow over the forecast period, owing to the factors such as the increasing number of spinal deformities among the population that experience an unstable movement of the lumbar spine or immobilizing a painful vertebral motion. For instance, as per a study published in the Journal of Orthopedics and Joint Surgery in August 2021, the prevalence of facet tropism (FT) was higher at the L4-L5 level, followed by L5-S1 among the South Indian population. In addition, as per the same source, a higher burden of facet tropism was observed in the elderly population aged 50 years and above. This is expected to increase the demand for spinal motion-preserving devices to further prevent the risk of disc degeneration, hence boosting the segment's growth.
Additionally, according to an article published in Neurology India in February 2022, oblique lumbar interbody fusion (OLIF) is better at treating lumbar spondylolisthesis than minimally invasive transforaminal lumbar interbody fusion (MISTLIF). The advantages offered by OLIF, such as less blood loss during surgery, providing better spinopelvic alignment, shorter duration of postoperative analgesics, and early return to work over MISTLIF, make it safe and effective in treating spinal issues. This is anticipated to increase its adoption for treating lumbar spinal fusion surgeries, bolstering the market's growth.
Key players dealing in the segment are scaling up their profit margins by engaging in diverse marketing tactics like mergers, acquisitions, and product launches. For instance, in October 2022, Stryker announced the launch of the Monterey AL Interbody System, a stand-alone interbody fusion device designed for anterior lumbar interbody fusion (ALIF). Similarly, in September 2022, Surgalign announced that it expanded its Fortilink product portfolio with a new family of interbody fusion devices. This is likely to provide ample growth opportunities to the segment studied in the future.
India Spinal Surgery Devices Market Competitor AnalysisThe Indian spinal surgery devices market is consolidated in nature. Key players are undertaking various strategic initiatives to gain market shares, such as mergers and acquisitions, technological collaborations, partnerships, and innovative product developments and launches. International players like Medtronic PLC, Stryker Corporation, Depuy Synthes Spine Inc. (Johnson & Johnson), Globus Medical Inc., Smith & Nephew PLC, Zimmer Biomet, and Orthofix Holding Inc. have already established their presence in the spinal surgery devices market in India.
Additional benefits of purchasing the report:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
This product will be delivered within 2 business days.
Table of Contents
1.2 Scope of the Study
4.2 Market Drivers
4.2.1 Rising Prevalence of Obesity and Degenerative Spinal Conditions
4.2.2 Increasing Adoption Rate of Minimally Invasive Spinal Surgeries
4.2.3 Increasing Number of Technological Advances in Spinal Surgery
4.3 Market Restraints
4.3.1 Expensive Treatment Procedures
4.3.2 Stringent Regulatory Process for New Product Approval
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5.1.1 Spinal Decompression
5.1.2 Spinal Fusion
22.214.171.124 Cervical Fusion
126.96.36.199 Interbody Fusion
188.8.131.52 ThoracoLumbar Fusion
184.108.40.206 Other Spinal Fusions
5.1.3 Fracture Repair Devices
5.1.4 Arthroplasty Devices
5.1.5 Non-fusion Devices
6.1.1 Medtronic PLC
6.1.2 Styker Corporation
6.1.3 Depuy Synthes Spine Inc. (Johnson & Johnson)
6.1.4 Globus Medical Inc.
6.1.5 Smith & Nephew PLC
6.1.6 Zimmer Biomet
6.1.7 Orthofix Holding Inc.
A selection of companies mentioned in this report includes:
- Medtronic PLC
- Styker Corporation
- Depuy Synthes Spine Inc. (Johnson & Johnson)
- Globus Medical Inc.
- Smith & Nephew PLC
- Zimmer Biomet
- Orthofix Holding Inc.